z-logo
open-access-imgOpen Access
Covalent binding of molecules to plasma immersion ion implantation‐activated microparticles for delivery into cells
Author(s) -
Kruse Hedi V.,
Tran Clara T. H.,
Zandwijk Nico,
Suchowerska Natalka,
McKenzie David R.,
Reid Glen
Publication year - 2020
Publication title -
engineering reports
Language(s) - English
Resource type - Journals
ISSN - 2577-8196
DOI - 10.1002/eng2.12087
Subject(s) - plasma immersion ion implantation , covalent bond , biomolecule , chemistry , surface modification , biophysics , drug delivery , nanotechnology , autofluorescence , fluorescence , conjugated system , small molecule , materials science , ion implantation , polymer , biochemistry , ion , physics , organic chemistry , quantum mechanics , biology
Delivery of biomolecules to target cells is an essential step in gene therapy, targeted drug delivery, and cell imaging, and can be achieved by encapsulation or conjugation to micro‐ or nanoparticles. For successful systemic delivery, these complexes must be stable under physiological conditions and prevent leakage of the cargo. Covalent binding of the active agent to a carrier is one‐way to facilitate this stability but frequently requires several steps. Here we show that plasma immersion ion implantation (PIII) treatment can activate the surface of paramagnetic polystyrene microparticles (MPs), increasing autofluorescence and allowing conjugation of biological molecules in a single‐step. Using PIII‐activated MPs, we demonstrate covalent binding of therapeutically relevant payloads including antibodies (Abs) and small‐interfering RNAs (siRNAs). The PIII‐activated magnetic particles were actively taken up by the cells, were nontoxic, and could be visualized due to increased autofluorescence induced by the PIII treatment. Ab and siRNA were effectively conjugated simultaneously to the active surface, and these functionalized MPs were also taken up by cells. This simple PIII‐based activation system has the potential to be applied to many different therapeutic approaches.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here